Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does NELARABINE Cause Gamma-glutamyltransferase increased? 5 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Gamma-glutamyltransferase increased have been filed in association with NELARABINE (Nelarabine). This represents 0.7% of all adverse event reports for NELARABINE.

5
Reports of Gamma-glutamyltransferase increased with NELARABINE
0.7%
of all NELARABINE reports
5
Deaths
5
Hospitalizations

How Dangerous Is Gamma-glutamyltransferase increased From NELARABINE?

Of the 5 reports, 5 (100.0%) resulted in death, 5 (100.0%) required hospitalization, and 4 (80.0%) were considered life-threatening.

Is Gamma-glutamyltransferase increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for NELARABINE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does NELARABINE Cause?

Febrile neutropenia (67) Drug ineffective (50) Myelopathy (47) Neurotoxicity (47) Neuropathy peripheral (45) Muscular weakness (42) Sepsis (39) Peripheral sensory neuropathy (38) Neutropenia (37) Off label use (37)

What Other Drugs Cause Gamma-glutamyltransferase increased?

FINGOLIMOD (635) ACETAMINOPHEN (442) METHOTREXATE (421) ATORVASTATIN (376) RIBOCICLIB (375) LETROZOLE (323) DEXAMETHASONE (292) CYCLOPHOSPHAMIDE (277) CARBOPLATIN (262) NIVOLUMAB (261)

Which NELARABINE Alternatives Have Lower Gamma-glutamyltransferase increased Risk?

NELARABINE vs NELFINAVIR NELARABINE vs NELVUTAMIG NELARABINE vs NEMOLIZUMAB NELARABINE vs NEMOLIZUMAB-ILTO NELARABINE vs NEOMYCIN

Related Pages

NELARABINE Full Profile All Gamma-glutamyltransferase increased Reports All Drugs Causing Gamma-glutamyltransferase increased NELARABINE Demographics